TrialCancer medicine2021

Maintenance treatment with rucaparib for recurrent ovarian carcinoma in ARIEL3, a randomized phase 3 trial: The effects of best response to last platinum-based regimen and disease at baseline on efficacy and safety.

Ana Oaknin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.